Bio-Techne Corp risk profile
38 Normal where most of the sector sits
Measured 21 October 2026 from TECH's filed statements. Recomputed nightly.
38 (Normal), driven by Competitive position at 56, over 6 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 28 | Normal | Stable | One-year price volatility — 43.4% |
| Operating pressure | 32 | Normal | Stable | Operating-margin drift — -3.9 percentage points |
| Cash conversion | 18 | Contained | Worsening | Capital spending against operating cash — 0.10x |
| Leverage and coverage | 1 | Contained | Easing | Current ratio — 4.55x |
| Competitive position | 56 | Elevated | Stable | Revenue-growth gap against peers — -23.1 percentage points |
| Concentration | 47 | Elevated | Stable | Geographic concentration — 3,466 HHI |
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.